330350 — Withus Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Annual balance sheet for Withus Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 June 30th	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	44,674	42,478	26,556	11,192	18,893
Net Total Accounts Receivable
Net Total Receivables	21,844	24,228	23,372	30,978	26,099
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	73,530	76,427	59,451	58,247	61,173
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19,383	25,379	39,843	49,945	49,236
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	107,013	118,979	119,395	130,780	134,687
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	24,161	23,975	25,572	31,011	33,938
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	30,253	38,074	36,359	40,502	41,571
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	76,759	80,905	83,036	90,278	93,117
Total Liabilities & Shareholders' Equity	107,013	118,979	119,395	130,780	134,687
Total Common Shares Outstanding